These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 31589917)

  • 21. Exposure to leucine induces oxidative stress in the brain of zebrafish.
    de Medeiros BZ; Wessler LB; Duarte MB; Lemos IS; Candiotto G; Canarim RO; Dos Santos PCL; Torres CA; Scaini G; Rico EP; Generoso JS; Streck EL
    Metab Brain Dis; 2022 Apr; 37(4):1155-1161. PubMed ID: 35275349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin improves behavioral parameters and oxidative stress in zebrafish submitted to a leucine-induced MSUD protocol.
    Duarte MB; Medeiros BZ; da Silva Lemos I; da Silva GL; Alano CG; Dondossola ER; Torres CA; Effting PS; Rico EP; Streck EL
    Metab Brain Dis; 2023 Aug; 38(6):2105-2114. PubMed ID: 37099078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine Improves Memory and Neurochemical Damage in a Model of Maple Syrup Urine Disease.
    Lemos IDS; Torres CA; Alano CG; Matiola RT; de Figueiredo Seldenreich R; Padilha APZ; De Pieri E; Effting PS; Machado-De-Ávila RA; Réus GZ; Leipnitz G; Streck EL
    Neurochem Res; 2024 Mar; 49(3):758-770. PubMed ID: 38104040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
    Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
    Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
    Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
    Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation in maple syrup urine disease.
    Wendel U; Saudubray JM; Bodner A; Schadewaldt P
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S60-4. PubMed ID: 10603101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of hemodialysis in maple syrup urine disease.
    Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ
    Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene analysis of maple syrup urine disease (MSUD)].
    Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
    Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Branched-Chain Amino Acids and Brain Metabolism.
    Sperringer JE; Addington A; Hutson SM
    Neurochem Res; 2017 Jun; 42(6):1697-1709. PubMed ID: 28417264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurological damage in MSUD: the role of oxidative stress.
    Sitta A; Ribas GS; Mescka CP; Barschak AG; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2014 Mar; 34(2):157-65. PubMed ID: 24220995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish.
    Wessler LB; Farias HR; Ronsani JF; Candiotto G; Dos Santos PCL; de Oliveira J; Rico EP; Streck EL
    Int J Dev Neurosci; 2019 Nov; 78():222-226. PubMed ID: 31589917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
    Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.